GlassScriptPhysician profile
David M Kruger
NPI 1881684918
$10,000.45
in general payments reported to CMS, 2019-2025
10 companies · $1,157 in 2025
The $1,157 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $912 · 2020: $79.15 · 2021: $453 · 2022: $703 · 2023: $401 · 2024: $6,296 · 2025: $1,157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,000 · Travel and Lodging: $2,393 · Food and Beverage: $1,460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,000.00 |
| Travel and Lodging | $2,393.38 |
| Food and Beverage | $1,460.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $8,469.22 | 2021-2025 | N/A, Everest Spinal System, Mako |
| Cutting Edge Spine, LLC | $450.00 | 2019 | |
| Depuy Synthes Sales INC. | $300.45 | 2019-2020 | |
| Cerapedics INC. | $248.76 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Seaspine Orthopedics Corporation | $156.94 | 2021 | |
| Pacira Therapeutics, INC. | $125.00 | 2019 | |
| Abbott Laboratories | $115.48 | 2019 | |
| Vb Spine LLC | $107.32 | 2025 | Monterey Al |
| Endo USA, INC. | $27.28 | 2025 | Xiaflex |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$265,166.60 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kruger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.